Fresenius Kabi

MOXIFLOXACIN HCL

Manufacturer:

Fresenius Kabi

Moxifloxacin Hcl HCPCS:

J2281

HCPCS Code Descriptor:

Injection, moxifloxacin (fresenius kabi) not therapeutically equivalent to j2280, 100 mg

Category:

J Code

Moxifloxacin Hcl NDCs:

63323-0850-74

Primary Type:

Antibiotic

Generic/Specialty Status:

Single-Source

Package Type:

Bag

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

63323-0850-74

About Moxifloxacin Hcl:

MOXIFLOXACIN HCL is an Antibiotic drug manufactured by Fresenius Kabi and administered via the Intravenous route of administration. The J Code: J2281 is aligned to the drug MOXIFLOXACIN HCL.

ACCESS PRICING AND MORE BY REGISTERING

J2281 Added Date:

January 1, 2023

J2281 Effective Date:

January 1, 2023

J2281 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Moxifloxacin Hcl billing and coding information.
Our team did not identify a source for Moxifloxacin Hcl patient assistance information. Please reach out to our team if you feel that this is a mistake.
MOXIFLOXACIN HCL prescribing information can be found at the link below:
Information regarding MOXIFLOXACIN HCL’s side effects can be found at MedlinePlus